Posted on 4/30/20
Boston Scientific Stock Rises on Sales Increase, Positive Management Outlook
A slowdown in medical procedures due to the COVID-19 pandemic caused a decline in first-quarter profits at medical device maker Boston Scientific (NYSE:BSX), but the company . . .
Posted on 4/29/20
XRHealth Partners with Pico Interactive
XRHealth, the leader in extended reality and therapeutic applications, announced they are partnering with Pico Interactive, a global tech company that develops innovative virtual reality (VR) . . .
Posted on 4/29/20
Syndax Proposes Public Offering of Common Stock
Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced today that it plans to offer and sell, subject . . .
Posted on 4/29/20
Current Health Launches a Collaboration with Mayo Clinic
BOSTON--(BUSINESS WIRE)--Current Health today announced that it has launched a collaboration with Mayo Clinic to develop remote monitoring solutions that accelerate the identification of COVID-19-positive patients . . .
Posted on 4/29/20
MinuteClinic Expands Options to Help Patients Access Routine Care During COVID-19 Pandemic
New MinuteClinic E-Clinic visit option enables patients to connect via video conferencing with a local provider As the nation continues to navigate the COVID-19 pandemic, CVS . . .
Posted on 4/29/20
Boston Scientific Announces Results For First Quarter 2020
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.543 billion during the first quarter of 2020. This represents growth of 2.0 percent on a reported basis, . . .
Posted on 4/29/20
Coronavirus Shopping Survey: 58 Million Americans Are Spending More Money – WalletHub
The coronavirus pandemic is changing the way the world shops, perhaps forever in some respects, so WalletHub conducted a nationally representative survey to see how Americans’ . . .
Posted on 4/29/20
Cherish Health and Health eVillages Launch Partnership
Cherish Health, a Cambridge technology innovator that pioneers solutions to improve lives and enable care using advanced sensors, artificial intelligence, medical evidence, and human touch, and . . .
Posted on 4/28/20
Arvinas Reports First Quarter 2020 Financial Results and Provides a Corporate Update
NEW HAVEN, Conn., April 28, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted . . .
Posted on 4/28/20
Inovio Pharmaceuticals, Mesoblast, and Moderna: Are These Red-Hot Biotech Stocks Still a Buy?
Although the COVID-19 pandemic hasn't been kind to most equities this year, some biotech and healthcare stocks have gotten a huge boost from this deadly respiratory . . .
Posted on 4/28/20
Applied BioMath Announces Collaboration with Xilio Therapeutics
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced a collaboration with . . .
Posted on 4/28/20
VBI Vaccines Closes Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--VBI Vaccines Inc. (Nasdaq: VBIV), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced the closing of its previously announced . . .
Posted on 4/28/20
Vertex Pharmaceuticals and Affinia Therapeutics Establish Multi-Year Collaboration
BOSTON & WALTHAM, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) and Affinia Therapeutics announced today that the two companies have entered into a strategic research collaboration to engineer . . .
Posted on 4/28/20
Biohaven Enters Into Agreement With Genpharm
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) and Genpharm Services, a leading partner for innovative pharmaceuticals in Dubai, announced today an agreement to distribute NURTEC™ ODT . . .
Posted on 4/27/20
States Where Social Distancing Is Most Difficult – WalletHub Study
Social distancing is the most effective way to prevent the spread of coronavirus, as the main way the virus spreads is through close contact between people. . . .
Posted on 4/27/20
70% of Investors Believe a COVID-19 Recession Will Be Worse Than 2008 -- But Here's the Silver Lining
COVID-19 has had a tremendous effect on millions of Americans' finances. With approximately 22 million U.S. adults filing for unemployment benefits over the last month and . . .
Posted on 4/26/20
Entasis Therapeutics Completes Initial Closing of $35M Private Placement with Innoviva
WALTHAM, Mass., April 22, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel . . .
Posted on 4/26/20
iCAD Prices $12.5M Registered Direct Offering
NASHUA, N.H., April 23, 2020 (GLOBE NEWSWIRE) -- iCAD, Inc. (Nasdaq: ICAD) today announced it has entered into definitive agreements with several institutional investors for the . . .
Posted on 4/26/20
State of Massachusetts Partners with Doctor On Demand
SAN FRANCISCO--(BUSINESS WIRE)--Doctor On Demand, the nation’s leading virtual care provider, this week launched a partnership with the Commonwealth of Massachusetts to provide free virtual medical . . .
Posted on 4/24/20
Genocea Biosciences: Don't Sleep On This Small Biotech
SummaryGenocea Biosciences is developing more precise and personalized cancer immunotherapies.Its ATLAS platform can identify an optimal antigen by using the patient's own T cell immune response . . .
Posted on 4/23/20
ProThera Biologics and Takeda Enter Global Licensing Agreement
ProThera Biologics, Inc. and Takeda Pharmaceutical Company Limited [TSE:4502/NYSE:TAK] ("Takeda") today announced that they have entered into a global licensing agreement to develop a novel plasma-derived . . .
Posted on 4/23/20
Peak Physical Therapy & Sports Performance Re-opens Clinics for Treatment
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide comprehensive treatment in orthopedic, spine and sports medicine specialties, has . . .
Posted on 4/23/20
Accent Therapeutics Announces $63 Million Series B
Accent Therapeutics, a biopharmaceutical company developing breakthrough treatments for cancer patients, announced today that it has completed a $63 million Series B financing.
Posted on 4/23/20
NeuroMetrix Reports Q1 2020 Financial Results
WOBURN, Mass., April 23, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2020. The . . .
Posted on 4/23/20
Why You're Smart to Buy Bristol Myers Squibb
Some decisions that we make lead to second-guessing ourselves. We wonder whether or not we made the best choice. But other decisions are ones that we . . .

